Would be nice to get some further data, but I can't see that the annual report - which refers to activities in the last year - will contain this. The next announcements should be about STORM and CANON trials, over the next few months. However anything could come out of left field and I was interested to read factor's post above which gives a new potential.
Montrachet, licensing CAVATAK for $200m seems a poor return on its potential. I'd hope for a lot more!
- Forums
- ASX - By Stock
- VLA
- Broker upgrade
Broker upgrade, page-21
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)